# Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation

> **NCT00298818** · — · COMPLETED · sponsor: **Northwell Health** · enrollment: 25 (actual)

## Conditions studied

- Epilepsy
- Mental Retardation
- Developmental Disabilities

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT00298818
- **Lead sponsor:** Northwell Health
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2002-08
- **Primary completion:** 2005-12
- **Final completion:** 2008-03
- **Target enrollment:** 25 (ACTUAL)
- **Last updated:** 2008-05-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00298818

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00298818, "Open Label Study of Zonisamide in the Treatment of Epilepsy in Patients With Mental Retardation". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00298818. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*